Endogenous Stimuli-Activatable Nanomedicine for Immune Theranostics for Cancer
文献类型：期刊论文
| 作者 | Wang, Weiqi1,2,3; Jin, Yilan1,2,3; Liu, Xiao1; Chen, Fangmin2,3; Zheng, Xiaohua1; Liu, Tianqing4; Yang, Yumin5,6; Yu, Haijun2,3
|
| 刊名 | ADVANCED FUNCTIONAL MATERIALS
 |
| 出版日期 | 2021-06-01 |
| 卷号 | 31期号:26页码:30 |
| 关键词 | cancer immunotherapy immune diagnosis nanomedicine stimuli-responsive tumor microenvironment |
| ISSN号 | 1616-301X |
| DOI | 10.1002/adfm.202100386 |
| 通讯作者 | Yang, Yumin(yangym@ntu.edu.cm) ; Yu, Haijun(hjyu@simm.ac.cn) |
| 英文摘要 | Cancer immunotherapy has witnessed significant advances in the past decade, however challenges associated with immune-related adverse effects and immunosuppressive tumor microenvironment, have hindered their clinical application. Stimuli-activatable nanomedicines hold great potential for improving the efficiency of cancer immunotherapy and minimizing the side effects via tumor-specific accumulation, controllable drug release profile, and combinational therapy by integrating multiple therapeutic regimens. In this review, the recent advances of stimuli-activatable nanomedicines for cancer immunotherapy are first described, with particular focus on endogenous stimuli including pH, glutathione, reactive oxygen species, and excessive enzymes within the tumor microenvironment. Then, the endogenous stimuli-activatable nanomedicines that target tumor cells, immune cells, or periphery immune systems for eliciting sustained systemic immune activation and modulating the immunosuppressive tumor microenvironment, are described. Next, the general mechanisms underlying nanomedicine-based immunotherapy by eliciting anti-tumor immune responses and overcoming immunologic tolerance are described. Further, the emerging application of bioimaging techniques for monitoring immune response and evaluating therapy performance is described. Finally, the authors' perspectives are provided for the clinical translation of nanomedicine-based cancer immunotherapy. |
| WOS关键词 | IMMUNOGENIC CELL-DEATH ; TUMOR-ASSOCIATED MACROPHAGES ; REGULATORY T-CELLS ; EXTRACELLULAR-MATRIX ; ANTITUMOR IMMUNITY ; CHECKPOINT BLOCKADE ; SUPPRESSOR-CELLS ; PHOTODYNAMIC THERAPY ; DENDRITIC CELLS ; IMMUNOTHERAPY |
| WOS研究方向 | Chemistry ; Science & Technology - Other Topics ; Materials Science ; Physics |
| 语种 | 英语 |
| WOS记录号 | WOS:000665207900041 |
| 出版者 | WILEY-V C H VERLAG GMBH |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/296840]  |
| 专题 | 新药研究国家重点实验室 |
| 通讯作者 | Yang, Yumin; Yu, Haijun |
| 作者单位 | 1.Nantong Univ, Sch Pharm, Nantong 226001, Peoples R China 2.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China 3.Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Pharmaceut, Shanghai 201203, Peoples R China 4.Western Sydney Univ, NICM Hlth Res Inst, Westmead, NSW 2145, Australia 5.Nantong Univ, Coinnovat Ctr Neuroregenerat, Key Lab Neuroregenerat Jiangsu, Nantong 226001, Peoples R China 6.Nantong Univ, Coinnovat Ctr Neuroregenerat, Minist Educ, Nantong 226001, Peoples R China |
| 推荐引用方式 GB/T 7714 | Wang, Weiqi,Jin, Yilan,Liu, Xiao,et al. Endogenous Stimuli-Activatable Nanomedicine for Immune Theranostics for Cancer[J]. ADVANCED FUNCTIONAL MATERIALS,2021,31(26):30. |
| APA | Wang, Weiqi.,Jin, Yilan.,Liu, Xiao.,Chen, Fangmin.,Zheng, Xiaohua.,...&Yu, Haijun.(2021).Endogenous Stimuli-Activatable Nanomedicine for Immune Theranostics for Cancer.ADVANCED FUNCTIONAL MATERIALS,31(26),30. |
| MLA | Wang, Weiqi,et al."Endogenous Stimuli-Activatable Nanomedicine for Immune Theranostics for Cancer".ADVANCED FUNCTIONAL MATERIALS 31.26(2021):30. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。